Insulet
PODD
#1041
Rank
S$24.92 B
Marketcap
$355.37
Share price
-0.81%
Change (1 day)
27.15%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): S$0.44 Billion

According to Insulet's latest financial reports the company's current earnings are S$1.98 Billion. In 2023 the company made an earning of S$0.33 Billion, an increase over its 2022 earnings that were of S$58.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.44 B31.75%
2023 S$0.33 B481.9%
2022 S$58.16 M-45.24%
2021 S$0.10 B43.35%
2020 S$74.08 M18.51%
2019 S$62.51 M41.16%
2018 S$44.28 M-711.95%
2017 -S$7.24 Million-56.85%
2016 -S$16.78 Million-79.31%
2015 -S$81.09 Million63.85%
2014 -S$49.49 Million31.04%
2013 -S$37.77 Million-21.96%
2012 -S$48.4 Million
2010 -S$46.16 Million-42.38%
2009 -S$80.11 Million-33.56%
2008 -S$0.13 Billion65.93%
2007 -S$72.66 Million209.75%
2006 -S$23.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$5.2 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.17 Billion-136.81%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.02 B 126.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.82 B 5,351.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.14 B 1,908.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$7.98 B 1,654.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$13.69 B 2,908.45%๐Ÿ‡บ๐Ÿ‡ธ USA